Swiss Investment Fund
for Emerging Markets

Search
Close this search box.
Search
Close this search box.

BioVeda China Fund III

BioVeda China Fund (BVCF) III L.P is a USD 188m private equity fund that invests in Chinese life sciences and healthcare growth companies. The fund is expected to commit to 12-15 companies, with ticket sizes over multiple rounds ranging typically from USD 5m – 30m. Target companies will be focused primarily on (i) pharmaceuticals/medicines products and delivery, (ii) medical technology devices, and (iii) bio-industrial and environmental technology with enterprise values ranging from USD 30m – 100m. The fund will seek to develop specifically innovative drugs and medical technology devices for the Chinese healthcare system and the healthcare delivery markets, which are servicing the broad majority of the population.

BioVeda China Fund III

BioVeda China Fund (BVCF) III L.P is a USD 188m private equity fund that invests in Chinese life sciences and healthcare growth companies. The fund is expected to commit to 12-15 companies, with ticket sizes over multiple rounds ranging typically from USD 5m – 30m. Target companies will be focused primarily on (i) pharmaceuticals/medicines products and delivery, (ii) medical technology devices, and (iii) bio-industrial and environmental technology with enterprise values ranging from USD 30m – 100m. The fund will seek to develop specifically innovative drugs and medical technology devices for the Chinese healthcare system and the healthcare delivery markets, which are servicing the broad majority of the population.

About the fund

BVCF III is the third fund of BVCF Management Ltd., a seasoned pioneer in healthcare investment management in China, headquartered in Shanghai, with an additional office in Beijing. The fund manager is led by former scientists Dr. Zhi Yang and Dr. Yi (Robert) Li, and works closely with its investee companies in the areas of business development, sales & marketing and strategy.

SIFEM committed USD 8m to the Fund and joins DFI investor IFC, as well as strategic and financial investors.

Investments by the fund

             
Date Name Country Industry Status
2016 Company 1 China Pharmaceuticals and biotech Active
2015 Company 2 United Kingdom Pharmaceuticals and biotech Active
2017 Company 3 China Medical equipment Active
2014 Company 4 China Pharmaceuticals and biotech Active
2014 Company 5 China Pharmaceuticals and biotech Active
2015 Company 6 China Pharmaceuticals and biotech Active
2014 Company 7 United States of America Pharmaceuticals and biotech Active
2017 Company 8 China Healthcare services Active
2013 Company 9 China Pharmaceuticals and biotech Active
2013 Company 10 China Pharmaceuticals and biotech Active
2013 Company 11 China Healthcare services Active
2016 Company 12 China Pharmaceuticals and biotech Active
2017 Company 13 China Healthcare services Active
2013 Company 14 China Chemicals and chemical products Active
2014 Company 15 China Healthcare services Active
Reference code
2012-03
Status
Active
Date of commmitment
August 2012
Date of exit
-
Fund size
USD
226,000,000
SIFEM commitment
USD
8,000,000
Asset class
Private Equity
Investment strategy
Investment through Fund
Fund manager
BVCF Management
Visit website
About us
Overview
Our mandate

Our investments

How we invest
Portfolio

Our impact

Impact system
Achievements
Overview
Our mandate
How we invest
Portfolio
Impact system
Achievements